|
1
|
Zecchina G, Ghio P, Bosio S, Cravino M,
Camaschella C and Scagliotti GV: Reactive thrombocytosis might
contribute to chemotherapy-related thrombophilia in patients with
lung cancer. Clin Lung Cancer. 8:264–267. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Albertsson P, Lennernas B and Norrby K:
Low-dose continuous 5-fluorouracil infusion stimulates
VEGF-A-mediated angiogenesis. Acta Oncol. 48:418–425. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Milanini-Mongiat J, Pouyssegur J and Pages
G: Identification of two Sp1 phosphorylation sites for p42/p44
mitogen-activated protein kinases: their implication in vascular
endothelial growth factor gene transcription. J Biol Chem.
277:20631–20639. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Karpatkin S: Does hypercoagulability
awaken dormant tumor cells in the host? J Thromb Haemost.
2:2103–2106. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sood SL: Cancer-associated thrombosis.
Curr Opin Hematol. 16:378–385. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rak J, Yu JL, Luyendyk J and Mackman N:
Oncogenes, trousseau syndrome, and cancer-related changes in the
coagulome of mice and humans. Cancer Res. 66:10643–10646. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sutherland DE, Weitz IC and Liebman HA:
Thromboembolic complications of cancer: epidemiology, pathogenesis,
diagnosis, and treatment. Am J Hematol. 72:43–52. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oberhoff C, Winkler UH, Hoffmann O and
Schindler AE: Adjuvant CMF-chemotherapy and haemostasis. Effect of
‘classical’ and ‘modified’ adjuvant CMF-chemotherapy on blood
coagulation fibrinolysis in patients with breast cancer. Eur J
Gynaecol Oncol. 21:147–152. 2000.PubMed/NCBI
|
|
9
|
Rella C, Coviello M, Giotta F, et al: A
prothrombotic state in breast cancer patients treated with adjuvant
chemotherapy. Breast Cancer Res Treat. 40:151–159. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nomura H, Wada H, Mizuno T, et al:
Elevated fibrin-related markers in patients with malignant diseases
suspected of having thrombotic disorders. Clin Appl Thromb Hemost.
16:266–272. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
American Heart Association, . Classes of
heart failure. http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heat-Failure_UCM_306328_Article.jspSeptember
6–2011
|
|
12
|
Baron JA, Gridley G, Weiderpass E, Nyren O
and Linet M: Venous thromboembolism and cancer. Lancet.
351:1077–1080. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Garcia-Avello A, Galindo-Alvarez J,
Martinez-Molina E, Cesar-Perez J and Navarro JL: Coagulative system
activation and fibrinolytic system inhibition activities arise from
tumoral draining vein in colon carcinoma. Thromb Res. 104:421–425.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gabazza EC, Taguchi O, Yamakami T, et al:
Alteration of coagulation and fibrinolysis systems after multidrug
anticancer therapy for lung cancer. Eur J Cancer. 30A:1276–1281.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Siemens HJ, Gerke P, Steinhoff J,
Roth-Isigkeit A, Wagner K and Bruckner S: A prolonged APTT in a
patient with a low grade malignant NHL - a case report.
Haematologica. 87:ELT082002.PubMed/NCBI
|
|
16
|
Tamizifar B, Oghab P and Esfahani MA: The
prediction role of D-dimer in recurrence of venous thromboembolism
1-year after anticoagulation discontinuing following idiopathic
deep vein thrombosis. J Res Med Sci. 19:586–591. 2014.PubMed/NCBI
|
|
17
|
Arpaia G, Carpenedo M, Verga M, et al:
D-dimer before chemotherapy might predict venous thromboembolism.
Blood Coagul Fibrinolysis. 20:170–175. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gadducci A, Marrai R, Baicchi U, et al:
Preoperative D-dimer plasma assay is not a predictor of clinical
outcome for patients with advanced ovarian cancer. Gynecol Oncol.
66:85–88. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Satoh T, Oki A, Uno K, et al: High
incidence of silent venous thromboembolism before treatment in
ovarian cancer. Br J Cancer. 97:1053–1057. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lippi G, Franchini M, Biasiutti C,
Dellagiacoma G, Salvagno GL and Guidi GC: Increased D-dimer value
and occult cancer in the absence of detectable thrombosis.
Haematologica. 92:e53–e55. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Oya M, Akiyama Y, Yanagida T, Akao S and
Ishikawa H: Plasma D-dimer level in patients with colorectal
cancer: its role as a tumor marker. Surg Today. 28:373–378. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sawaguchi K, Yabushita H, Higuchi K, et
al: Effect of remission induction chemotherapy on blood
coagulability in patients with gynecological malignancies. Nippon
Gan Chiryo Gakkai Shi. 24:798–808. 1989.(In Japanese). PubMed/NCBI
|
|
23
|
Yigit E, Gonullu G, Yucel I, Turgut M,
Erdem D and Cakar B: Relation between hemostatic parameters and
prognostic/predictive factors in breast cancer. Eur J Intern Med.
19:602–607. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Batschauer AP, Figueiredo CP, Bueno EC, et
al: D-dimer as a possible prognostic marker of operable hormone
receptor-negative breast cancer. Ann Oncol. 21:1267–1272. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lyman GH: Thromboprophylaxis with
low-molecular-weight heparin in medical patients with cancer.
Cancer. 115:5637–5650. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Di Nisio M, Klerk CP, Meijers JC and
Büller HR: The prognostic value of the D-dimer test in cancer
patients treated with and without low-molecular-weight heparin. J
Thromb Haemost. 3:1531–1533. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sousou T and Khorana AA: New insights into
cancer-associated thrombosis. Arterioscler Thromb Vasc Biol.
29:316–320. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gerotziafas GT, Papageorgiou C, Hatmi M,
Samama MM and Elalamy I: Clinical studies with anticoagulants to
improve survival in cancer patients. Pathophysiol Haemost Thromb.
36:204–211. 2008. View Article : Google Scholar : PubMed/NCBI
|
